Cargando…

How Health Professionals Conceptualize and Represent Placebo Treatment in Clinical Trials and How Their Patients Understand It: Impact on Validity of Informed Consent

CONTEXT: Previous studies suggested that many patients, who have given their informed consent to participate in randomized controlled trials (RCT), have somewhat limited understanding of what a placebo treatment is. We hypothesized that the relationship between patients and their health professional...

Descripción completa

Detalles Bibliográficos
Autores principales: Keller, Pascal-Henri, Grondin, Olivier, Tison, François, Gonon, Francois
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873029/
https://www.ncbi.nlm.nih.gov/pubmed/27195806
http://dx.doi.org/10.1371/journal.pone.0155940
_version_ 1782432824385601536
author Keller, Pascal-Henri
Grondin, Olivier
Tison, François
Gonon, Francois
author_facet Keller, Pascal-Henri
Grondin, Olivier
Tison, François
Gonon, Francois
author_sort Keller, Pascal-Henri
collection PubMed
description CONTEXT: Previous studies suggested that many patients, who have given their informed consent to participate in randomized controlled trials (RCT), have somewhat limited understanding of what a placebo treatment is. We hypothesized that the relationship between patients and their health professionals plays a central role in this understanding. METHODS: We interviewed 12 patients included in RCTs (nine suffering from Parkinson’s disease and three from Huntington’s disease) and 18 health professionals involved with RCTs (eight principal investigators, four associated physicians and six clinical research associates). Semi-structured interviews were conducted after the RCTs had ended but before the treatment allocation was revealed. RESULTS: Only two patients clearly understood the aim of placebo-controlled RCTs. Only one principal investigator said she asks all her patients whether they agree to participate in RCTs. The seven others said they only ask patients who seem more likely to be compliant. Their selection criteria included docility and personality traits associated in other studies with enhanced placebo responses. According to 13 of the 18 health professionals, their relationship with patients may influence the amplitude of the placebo response. All but one clinical research associates added that the placebo response could result from a “maternal” type of care. All principal investigators said they have a strong influence on their patient's decision to participate. Finally, when interviewees were asked to narrate a memory of a medically unexplained healing, in eight of 11 physicians' narratives the beneficiary was a child while in 10 of 12 patients' narratives it was an adult. CONCLUSION: Our observations suggest that the interrelationship between health professionals and patients involved in RCTs could be compared to that between parents and children. Therefore, adherence to formal rules regarding informed consent does not ensure a balanced relationship between patients and health professionals.
format Online
Article
Text
id pubmed-4873029
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-48730292016-06-09 How Health Professionals Conceptualize and Represent Placebo Treatment in Clinical Trials and How Their Patients Understand It: Impact on Validity of Informed Consent Keller, Pascal-Henri Grondin, Olivier Tison, François Gonon, Francois PLoS One Research Article CONTEXT: Previous studies suggested that many patients, who have given their informed consent to participate in randomized controlled trials (RCT), have somewhat limited understanding of what a placebo treatment is. We hypothesized that the relationship between patients and their health professionals plays a central role in this understanding. METHODS: We interviewed 12 patients included in RCTs (nine suffering from Parkinson’s disease and three from Huntington’s disease) and 18 health professionals involved with RCTs (eight principal investigators, four associated physicians and six clinical research associates). Semi-structured interviews were conducted after the RCTs had ended but before the treatment allocation was revealed. RESULTS: Only two patients clearly understood the aim of placebo-controlled RCTs. Only one principal investigator said she asks all her patients whether they agree to participate in RCTs. The seven others said they only ask patients who seem more likely to be compliant. Their selection criteria included docility and personality traits associated in other studies with enhanced placebo responses. According to 13 of the 18 health professionals, their relationship with patients may influence the amplitude of the placebo response. All but one clinical research associates added that the placebo response could result from a “maternal” type of care. All principal investigators said they have a strong influence on their patient's decision to participate. Finally, when interviewees were asked to narrate a memory of a medically unexplained healing, in eight of 11 physicians' narratives the beneficiary was a child while in 10 of 12 patients' narratives it was an adult. CONCLUSION: Our observations suggest that the interrelationship between health professionals and patients involved in RCTs could be compared to that between parents and children. Therefore, adherence to formal rules regarding informed consent does not ensure a balanced relationship between patients and health professionals. Public Library of Science 2016-05-19 /pmc/articles/PMC4873029/ /pubmed/27195806 http://dx.doi.org/10.1371/journal.pone.0155940 Text en © 2016 Keller et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Keller, Pascal-Henri
Grondin, Olivier
Tison, François
Gonon, Francois
How Health Professionals Conceptualize and Represent Placebo Treatment in Clinical Trials and How Their Patients Understand It: Impact on Validity of Informed Consent
title How Health Professionals Conceptualize and Represent Placebo Treatment in Clinical Trials and How Their Patients Understand It: Impact on Validity of Informed Consent
title_full How Health Professionals Conceptualize and Represent Placebo Treatment in Clinical Trials and How Their Patients Understand It: Impact on Validity of Informed Consent
title_fullStr How Health Professionals Conceptualize and Represent Placebo Treatment in Clinical Trials and How Their Patients Understand It: Impact on Validity of Informed Consent
title_full_unstemmed How Health Professionals Conceptualize and Represent Placebo Treatment in Clinical Trials and How Their Patients Understand It: Impact on Validity of Informed Consent
title_short How Health Professionals Conceptualize and Represent Placebo Treatment in Clinical Trials and How Their Patients Understand It: Impact on Validity of Informed Consent
title_sort how health professionals conceptualize and represent placebo treatment in clinical trials and how their patients understand it: impact on validity of informed consent
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873029/
https://www.ncbi.nlm.nih.gov/pubmed/27195806
http://dx.doi.org/10.1371/journal.pone.0155940
work_keys_str_mv AT kellerpascalhenri howhealthprofessionalsconceptualizeandrepresentplacebotreatmentinclinicaltrialsandhowtheirpatientsunderstanditimpactonvalidityofinformedconsent
AT grondinolivier howhealthprofessionalsconceptualizeandrepresentplacebotreatmentinclinicaltrialsandhowtheirpatientsunderstanditimpactonvalidityofinformedconsent
AT tisonfrancois howhealthprofessionalsconceptualizeandrepresentplacebotreatmentinclinicaltrialsandhowtheirpatientsunderstanditimpactonvalidityofinformedconsent
AT gononfrancois howhealthprofessionalsconceptualizeandrepresentplacebotreatmentinclinicaltrialsandhowtheirpatientsunderstanditimpactonvalidityofinformedconsent